Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol

BACKGROUND: Combination of chemotherapies (fluoropirimidines, oxaliplatin and irinotecan) with biologic drugs (bevacizumab, panitumumab, cetuximab) have improved clinical responses and survival of metastatic colorectal cancer (mCRC). However, patients’ selection thorough the identification of predic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Ottaiano, Alessandro, Scala, Stefania, Normanno, Nicola, Napolitano, Maria, Capozzi, Monica, Rachiglio, Anna Maria, Roma, Cristin, Trotta, Anna Maria, D’Alterio, Crescenzo, Portella, Luigi, Romano, Carmela, Cassata, Antonino, Casaretti, Rossana, Silvestro, Lucrezia, Nappi, Anna, Tafuto, Salvatore, Avallone, Antonio, De Stefano, Alfonso, Tamburini, Mario, Picone, Carmine, Petrillo, Antonella, Izzo, Francesco, Palaia, Raffaele, Albino, Vittorio, Amore, Alfonso, Belli, Andrea, Pace, Ugo, Di Marzo, Massimiliano, Chiodini, Paolo, Botti, Gerardo, De Feo, Gianfranco, Delrio, Paolo, Nasti, Guglielmo
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6734266/
https://ncbi.nlm.nih.gov/pubmed/31500586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6109-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados